DR. GLODERM TABRX WRINKLETOX (ADENOSINE) CREAM [DR.GLODERM]

DR. GLODERM TABRX WRINKLETOX (ADENOSINE) CREAM [DR.GLODERM]
PDF | XML

NDC 71342-0013-1
Set ID 4bc3ee16-98b9-4e80-e054-00144ff88e88
Category HUMAN OTC DRUG LABEL
Packager DR.GLODERM
Generic Name
Product Class Adenosine Receptor Agonist
Product Number
Application Number
  • ACTIVE INGREDIENT

    Adenosine

  • INACTIVE INGREDIENT

    Water, Butylene Glycol, etc.

  • PURPOSE

    Skin Protectant - Anti-Wrinkle

  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children

  • INDICATIONS & USAGE

    It's melting on the pam taken two capsules with spatula at the last stage of skin care, and apply on the entire face.

    Gently pat to help absorption into the skin.

    * Do not eat capsules.

  • WARNINGS

    1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).

    1) Occurrence of red spots, swelling, itchiness, and other skin irritation

    2) If the symptoms above occur after the application area is exposed to direct sunlight

    2. Do not use on open wounds, eczema, and other skin irritations

    3. Precaution for Storage and Handling

    1) Close the lid after use

    2) Keep out of reach of infants and children

    3) Do not to store in a place with high/low temperature and exposed to direct sunlight

    4. Use as avoiding eye areas.

  • DOSAGE & ADMINISTRATION

    for external use only


  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    DR. GLODERM TABRX WRINKLETOX 
    adenosine cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71342-0013
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE0.0428 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    GLYCERIN (UNII: PDC6A3C0OX)  
    WATER (UNII: 059QF0KO0R)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71342-0013-145 g in 1 JAR; Type 0: Not a Combination Product03/28/2017
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other03/01/2017
    Labeler - DR.GLODERM (694773267)
    Registrant - DR.GLODERM (694773267)
    Establishment
    NameAddressID/FEIBusiness Operations
    SAMSUNG MEDICOS. CO., LTD. Hyangnam Factory689851701manufacture(71342-0013)
    Establishment
    NameAddressID/FEIBusiness Operations
    DR.GLODERM694773267label(71342-0013)

Related Drugs